HIGHLIGHTS
- who: Yidan Qiao from the Southwest University, China have published the Article: Pam2CSK4-adjuvanted SARS-CoV-2 RBD nanoparticle vaccine induces robust humoral and cellular immune responses, in the Journal: (JOURNAL)
- what: The authors intended to construct a CHO-GS cell line by inserting ST(SpyTag)-RBD-GS at the GAPDH site for steadily producing RBD protein . Together, the authors provide an important theoretical principle of the combination of SARS-CoV-2 NP vaccine and adjuvant for clinical transformation.
- how: Mice experiments were carried out in concert with the guidelines and regulations of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.